Rodríguez-Hernández Pedro Javier, Canals-Baeza Alejandro, Santamaria-Orleans Alicia, Cachadiña-Domenech Ferran
Child and Adolescent Psychiatric Unit, Nuestra Señora de Candelaria University Hospital, Tenerife, Spain.
Paediatrics, CS Alicante-Sta Faz, Alicante, Spain.
J Diet Suppl. 2020;17(1):1-12. doi: 10.1080/19390211.2018.1481165. Epub 2018 Oct 31.
The aim of this study was to assess the impact of omega-3 fatty acid supplementation among other nonpharmacological treatments on mental health and quality of life (QOL) of children with behavioral disorders. An observational multicenter study of 6- to 12-year-old children with behavior-related problems was performed in Spain with a three-month follow-up assessment. The Kidscreen-10 and Strengths and Difficulties Questionnaires (SDQ) were used to assess effectiveness of each intervention. Characteristics of study population were compared with those of the general population. Subanalyses of two homogenous subgroups, who received versus did not receive dietary supplementation with omega-3 fatty acids, were performed. The study included 942 children (69.1% male) with a mean (SD) age of 8.5 (1.8) years. Overall, patients' health status and QOL significantly improved at three months ( < .001). Scores on the SDQ also improved, with significant reductions on all subscales ( < .05). Comparison of SDQ results with the same-age general population showed higher overall scores in the study population (8.5 [5.5] vs. 18.6 [8.1], respectively) and on all the subscales ( < .001 in all cases). The omega-3 fatty acid supplementation subgroup presented greater improvements in each category of SDQ ( < .05), except for the emotion subscale. Omega-3 fatty acid supplementation alone or in combination with other nonpharmacological treatments is effective in improving children's mental health. Overall, nonpharmacological recommendations currently made by pediatricians seem to be effective in improving the perceived health status and patients' QOL and in the reduction of health problems, especially hyperactivity/inattention and conduct problems.
本研究的目的是评估ω-3脂肪酸补充剂在其他非药物治疗中对行为障碍儿童心理健康和生活质量(QOL)的影响。在西班牙对6至12岁有行为相关问题的儿童进行了一项观察性多中心研究,并进行了为期三个月的随访评估。使用儿童生活质量量表10(Kidscreen-10)和长处与困难问卷(SDQ)来评估每种干预措施的效果。将研究人群的特征与一般人群的特征进行比较。对接受和未接受ω-3脂肪酸膳食补充剂的两个同质亚组进行了亚分析。该研究纳入了942名儿童(69.1%为男性),平均(标准差)年龄为8.5(1.8)岁。总体而言,患者的健康状况和生活质量在三个月时显著改善(P<0.001)。SDQ评分也有所改善,所有子量表的得分均显著降低(P<0.05)。将SDQ结果与同年龄的一般人群进行比较,研究人群的总体得分更高(分别为8.5[5.5]和18.6[8.1]),且所有子量表得分均更高(所有情况P<0.001)。ω-3脂肪酸补充剂亚组在SDQ的每个类别中都有更大的改善(P<0.05),情绪子量表除外。单独或与其他非药物治疗联合使用ω-3脂肪酸补充剂可有效改善儿童心理健康。总体而言,儿科医生目前提出的非药物建议似乎可有效改善感知健康状况和患者生活质量,并减少健康问题,尤其是多动/注意力不集中和行为问题。